Lri Investments, LLC Bio N Tech Se Transaction History

Lri Investments, LLC

$746 Billion
Q1 2024

A detailed history of Lri Investments, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Lri Investments, LLC holds 181 shares of BNTX stock, worth $14,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

181

Holding current value

$14,545

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 21, 2024	SELL	$88.96 - $112.35 $6,316 - $7,976	-71 Reduced 39.23%	110 $10.1 Million
Q1 2024 May 14, 2024	BUY	$88.96 - $112.35 $16,101 - $20,335	181 New	181 $16.7 Million

Others Institutions Holding BNTX

# of Institutions

326

Shares Held

40.4M

Call Options Held

1.31M

Put Options Held

1.37M

Baillie Gifford & CO

8.36M
Shares

$672 Million
0.61% of portfolio
Primecap Management CO Pasadena, CA

4.81M
Shares

$386 Million
0.34% of portfolio
Harding Loevner LP Bridgewater, NJ

3.82M
Shares

$307 Million
2.24% of portfolio
Flossbach Von Storch Ag Cologne, 2M

3.47M
Shares

$279 Million
1.4% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

3.43M
Shares

$276 Million
1.76% of portfolio

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.

Account